Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (NCT07296263) titled 'Evaluation of Gadolinium Based Contrast Agents for Portable MR Imaging Systems' on Dec. 17, 2025.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Other. Masking: None (Open Label).
Primary Sponsor: Hyperfine
Condition:
Intra-axial Tumors
Extra-axial Tumors
Infection/Inflammatory Lesions
Intervention:
Other: Evaluation of Gadolinium Based Contrast Agents (GBCA) for Portable MR Imaging Systems
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: December 31, 2025
Target Sample Size: 85
Countries of Recruitment:
Uni...